hrvatski jezikClear Cookie - decide language by browser settings

Design, synthesis and biological evaluation of biscarbamates as potential selective butyrylcholinesterase inhibitors fot the treatment of Alzheimer`s disease

Matošević, Ana; Knežević, Anamarija; Zandona, Antonio; Maraković, Nikola; Kovarik, Zrinka; Bosak, Anita (2022) Design, synthesis and biological evaluation of biscarbamates as potential selective butyrylcholinesterase inhibitors fot the treatment of Alzheimer`s disease. Pharmaceuticals, 15 (10). ISSN 1424-8247

[img]
Preview
PDF - Published Version - article
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

As butyrylcholinesterase (BChE) plays a role in the progression of symptoms and pathophysiology of Alzheimer’s disease (AD), selective inhibition of BChE over acetylcholinesterase (AChE) can represent a promising pathway in treating AD. The carbamate group was chosen as a pharmacophore because the carbamates currently or previously in use for the treatment of AD displayed significant positive effects on cognitive symptoms. Eighteen biscarbamates with different substituents at the carbamoyl and hydroxyaminoethyl chain were synthesized, and their inhibitory potential toward both cholinesterases and inhibition selectivity were determined. The ability of carbamates to cross the blood–brain barrier (BBB) by passive transport, their cytotoxic profile and their ability to chelate biometals were also evaluated. All biscarbamates displayed a time-dependent inhibition with inhibition rate constants within 10−3–10−6 M−1 min−1 range for both cholinesterases, with generally higher preference to BChE. For two biscarbamates, it was determined that they should be able to pass the BBB by passive transport, while for five biscarbamates, this ability was slightly limited. Fourteen biscarbamates did not exhibit a cytotoxic effect toward liver, kidney and neuronal cells. In conclusion, considering their high BChE selectivity, non-toxicity, ability to chelate biometals and pass the BBB, compounds 2 and 16 were pointed out as the most promising compounds for the treatment of middle and late stages of AD.

Item Type: Article
Uncontrolled Keywords: acetylcholinesterase ; metal chelating ; detailed kinetic study ; spontaneous decarbamylation ; rate constants ; molecular docking
Subjects: NATURAL SCIENCES > Chemistry
BIOMEDICINE AND HEALTHCARE > Pharmacy
Divisions: Division of Organic Chemistry and Biochemistry
Projects:
Project titleProject leaderProject codeProject type
Analiza interakcija butirilkolinesteraze s novim inhibitorima i reaktivatorimaKovarik, ZrinkaIP-2018-01-7683HRZZ
Razvoj bioaktivnih molekula za tretman neurodegenerativnih bolestiBosak, AnitaIP-2020-02-9343HRZZ
Depositing User: Anamarija Knežević
Date Deposited: 04 Apr 2023 11:55
URI: http://fulir.irb.hr/id/eprint/7844
DOI: 10.3390/ph15101220

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

Contrast
Increase Font
Decrease Font
Dyslexic Font
Accessibility